FDA Inspection 1257940 — Baxalta US Inc.

Baxalta US Inc. — FEI 3013980449

The FDA completed an inspection of Baxalta US Inc. on January 30, 2025 in Social Circle, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 30, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Social Circle, GA (United States)